Federal grant · project grant (b)
We Propose to Generate Non-transgenic HLB Resistant Citrus Varieties via Genome Editing of Citrus Susceptibility (S) Genes to HLB Using CRISPR/CAS9 Technology. Our Central Hypothesis Is That Candidatus Liberibacter Asiaticus (las), Which Utilizes a Set of Bacterial Secreted Effector Proteins to Manipulate Key Disease S Gene(s), Can Be Eliminated by Modification of Key S Gene(s). We Propose to Characterize the Interaction Between Las Effectors and Key S Genes or Their Products. Multiple Candidate S Genes Based on Interactions With Key Effectors Have Been Identified in Our Preliminary Study. We Will Generate Mutations in the Candidate S Genes Using CRISPR-CAS9 and Screen the Mutants for Resistance to HLB. the Confirmed S Gene(s) Will Be Modified in Additional Selected Citrus Scion and Rootstock Varieties. in Parallel, We Will Construct Mutations in the Key S Genes to Pinpoint the Critical Residues for Interactions With Las Effectors, Which Will Assist in Directing Plant Modifications and Validation of Identified Resistant Lines. This Proposal Addresses One of the Six Areas of Highest Priority Determined by the Citrus Disease Sub-committee (CDS): Development of Tolerance or Resistance to HLB in Cultivars Commercially Important in All Citrus Production Regions. the Strategy to Be Employed and the Objectives Are Developed Based on Input From Citrus Industry. Citrus Grower Sponsored Projects Established the Foundation of This Application, E.g., Adoption of Crispr Technology on Citrus. the Non-transgenic Plants Generated Here May Not Be Regulated by Usda and Could Be Commercialized Immediately, If Proven HLB Resistant and With Acceptable Horticultural Traits.
Committed
$3.4 Million
Paid out
$2.6M
77%
Committed, not yet paid
$788.4K
23%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…